NEURO2022

Session information

Wakate Dojo

[2WD07a2] Wakate Dojo: Disorder Model

Fri. Jul 1, 2022 3:00 PM - 4:00 PM Room 7 (Conference Building A2 (Okinawa Convention Center))

Chair: Takashi Shichita

*Katherine R Meckel1,2, Rebecca S Hofford2,3, Arthur Godino1,2, Emily G Peck4, Erin S Calipari5, Drew D Kiraly1,2,3 (1. Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, 2. The Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, 3. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, 4. Department of Physiology and Pharmacology, Wake Forest School of Medicine, 5. Department of Pharmacology, Vanderbilt University)

*Yasutaka Mukai1,2, Michael Lazarus3, Takeharu Nagai4, Kenji F Tanaka5, Akihiro Yamanaka1,2 (1. Neuroscience 2, RIEM, Nagoya University, 2. Dept of Neural Regulation, Grad Sch Med, Nagoya Univ, Nagoya, Japan, 3. WPI-IIIS, Tsukuba Univ, Tsukuba, Japan, 4. Dept Biomol Sci and Eng, ISIR, Osaka Univ, Osaka, Japan, 5. Dept of Neuropsychiatry, Sch of Med, Keio Univ, Tokyo, Japan)

*Takumi Nakamura1,2, Kazuo Nakajima1, Toru Yoshihara3, Kurara Takano1, Chiharu Tanegashima4, Mitsutaka Kadota4, Manabu Toyoshima1, Yuki Kobayashi1, Junko Ueda1, Shigeyoshi Itohara1, Takeo Yoshikawa1, Shigehiro Kuraku4, Masahide Asano3, Takaoki Kasahara1, Takashi Tsuboi5, Atsushi Takata1, Tadafumi Kato2 (1. RIKEN Center for Brain Science, 2. Juntendo University Graduate School of Medicin, 3. Kyoto University Graduate School of Medicine, 4. RIKEN Center for Biosystems Dynamics Research, 5. Graduate School of Arts and Sciences, The University of Tokyo)

*Aika Kosuge1, Kazuo Kunisawa1, Hiroyuki Tezuka2, Masato Hoshi3, Nanaka Morita4, Tomoki Kawai1, Kuniaki Saito4,5,6, Toshitaka Nabeshima5,6, Akihiro Mouri1,6 (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan, 2. Department of Cellular Function Analysis, Research Promotion and Support Headquarters, Fujita Health University, Aichi, Japan, 3. Department of Biochemical and Analytical Sciences, Fujita Health University, 4. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Sciences, Aichi, Japan, 5. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan, 6. Japanese Drug Organization of Appropriate Use and Research (J-DO), Aichi, Japan)

×

Authentication

Abstract password authentication.
A password is required to view the full text of the abstract. Please enter the following password.

PW: Neuro2022

×

Please log in with your participant account.
» Participant Log In